These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 84045)

  • 41. Cell-mediated cytotoxicity patterns of cloned cytotoxic T lymphocytes. Cytotoxicity directed against canine lymphoblasts, monocytes, and endothelial cells.
    Groenewegen G; Buurman WA; van der Linden CJ; Jeunhomme GM; Kootstra G
    Transplantation; 1985 Jun; 39(6):657-60. PubMed ID: 2408367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recognition of target cell determinants associated with DLA-D-locus-encoded antigens by canine cytotoxic lymphocytes.
    Raff RF; Storb R; Ladiges WC; Deeg HJ
    Transplantation; 1985 Sep; 40(3):323-8. PubMed ID: 2412323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Target determinants in CML identified by cytotoxic effector cells generated against HLA antigens in strong genetic linkage disequilibrium.
    Kim SJ; Christiansen F; Silver DM; Dupont B
    Transplant Proc; 1981 Mar; 13(1 Pt 2):982-7. PubMed ID: 6168078
    [No Abstract]   [Full Text] [Related]  

  • 44. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA-A, -B, and -DR specificities on human monocytes.
    Merdrignac G; Fauchet R; Bouhallier O; Genetet B
    Tissue Antigens; 1981 Nov; 18(5):299-305. PubMed ID: 6178177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Dec; 158(6):1804-21. PubMed ID: 6196431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary in vitro generation of cytotoxic cells specific for human minor histocompatibility antigens between HLA-identical siblings.
    Tekolf WA; Shaw S
    J Immunol; 1984 Apr; 132(4):1756-60. PubMed ID: 6199410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serological identification of five HLA-D associated (Ia-like) determinants.
    Albrechtsen D; Solheim BG; Thorsby E
    Tissue Antigens; 1977 Mar; 9(3):153-62. PubMed ID: 67654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The human major histocompatibility complex HLA: some recent developments.
    Thorsby E
    Transplant Proc; 1979 Mar; 11(1):616-23. PubMed ID: 88091
    [No Abstract]   [Full Text] [Related]  

  • 52. Low responsiveness in MLC induced by certain HLA--A antigens on the stimulator cells.
    Thomsen M; Dickmeiss E; Jakobsen BK; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1978 May; 11(5):449-56. PubMed ID: 80834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human Ia-like DRw lymphocyte antigens stimulating activity in primary mixed lymphocyte reaction.
    Fradelizi D; Nunez-Roldan A; Sasportes M
    Eur J Immunol; 1978 Feb; 8(2):88-93. PubMed ID: 77783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system.
    Markert ML; Cresswell P
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6101-4. PubMed ID: 6160591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Kinetics of the appearance of HLA-DR antigens on human alloactivated T lymphocytes and the demonstration of new antigenic determinants].
    Wollman EE; Lepage V; Delima M; Fradelizi D; Degos L; Dausset J
    C R Seances Acad Sci D; 1980 Nov; 291(9):757-61. PubMed ID: 6162584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA restriction of secondary mumps-specific cytotoxic T lymphocytes.
    Kress HG; Kreth HW
    J Immunol; 1982 Aug; 129(2):844-9. PubMed ID: 6177787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
    Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.